Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project

European Respiratory Journal

Volumn 39, Issue 6, 2012, Pages 1343-1353

  Hooper, Richard ^a   Burney, Peter ^a   Vollmer, William M ^b   McBurnie, Mary Ann ^b   Gislason, Thorarinn ^d   Tan, Wan C ^e   Jithoo, Anamika ^a   Kocabas, Ali ^f   Weltee, Tobias ^g   Buist, A Sonia ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Age; Chronic obstructive pulmonary disease; Early life; Risk factor; Smoking; Tuberculosis

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OBESITY; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SPIROMETRY;

ADULT; AGED; BODY MASS INDEX; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY; TOBACCO SMOKE POLLUTION; TUBERCULOSIS, PULMONARY;

EID: 84861888193     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00002711     Document Type: Article

References (51)

1. World Health Organization. The GOLD global strategy for the management and prevention of COPD, 2001. www.goldcopd.org. Date last accessed: February 1, 2012.
2. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not ,70%. Chest 2007; 131: 349-355.
3. Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
4. Murray C. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
5. Nielsen R, Johannessen A, Benediktsdottir B, et al. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J 2009; 34: 850-857.
6. Anthonisen N, Skeans M, Wise R, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
7. Pelkonen M, Notkola I, Tukiainen H, et al. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the finnish cohorts of the seven countries study. Thorax 2001; 56: 703-707.
8. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. JAMA 1994; 272: 1497-1505.
9. Wilson D, Adams R, Appleton S, et al. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. Chest 2005; 128: 2035-2042.
10. Downs SH, Schindler C, Liu LS, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007; 357: 2338-2347.
11. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134: 1011-1019.
12. Barker DJ, Osmond C. Childhood respiratory infection and adult chronic bronchitis in England and Wales. BMJ 1986; 293: 1271-1275.
13. Lawlor DA, Ebrahim S, Davey Smith G. Association between self-reported childhood socioeconomic position and adult lung function: findings from the British women's heart and health study. Thorax 2004; 59: 199-203.
14. Barker DJP, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303: 671-675.
15. Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD 2005; 2: 277-283.
16. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741-750.
17. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
19. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978 12, 118: 1-120.
20. Burney P, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
21. Fazzi P, Viegi G, Paoletti P, et al. Comparison between two standardized questionnaires and pulmonary function tests in a group of workers. Eur J Respir Dis 1982; 63: 168-169.
22. Lundback B, Stjernberg N, Nystrom L, et al. An interview study to estimate prevalence of asthma and chronic bronchitis. the obstructive lung disease in northern Sweden study. Eur J Epidemiol 1993; 9: 123-133.
23. Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. 2nd Edn. New York, Wiley, 2000.
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc B 1995; 57: 289-300.
25. DerSimonian R, Laird N. Meat-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
26. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ Clin Res 2003; 327: 557-560.
27. Mathur N, Rastogi SK, Gupta BN, et al. A global comparison of predicting equations on spirometry in the male population. Int J Epidemiol 1990; 19: 331-338.
28. Hansen J, Sun X, Wasserman K. Ethnic- and sex-free formulae for detection of airway obstruction. Am J Respir Crit Care Med 2006; 174: 493-498.
29. Al-Rawas O, Baddar S, Al-Maniri A, et al. Normal spirometric reference values for Omani adults. Lung 2009; 187: 245-251.
30. Swanney MP, Jensen RL, Crichton DA, et al. FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162: 917-919.
31. Surgeon General. The health consequences of smoking: chronic obstructive lung disease. Rockville, US Department of Health and Human Services, 1984. Report no. DHHS (PHS) 84-50205.
32. Eisner MD, Yelin EH, Henke J, et al. Environmental tobacco smoke and adult asthma. Am J Respir Crit Care Med 1998; 158: 170-175.
33. Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou biobank cohort study. Lancet 2007; 370: 751-757.
34. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54: 1119-1138.
35. Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36: 1034-1041.
36. McKeever T, Lewis S, Cassano P, et al. Patterns of dietary intake and relation to respiratory disease, forced expiratory volume in 1 s, and decline in 5-y forced expiratory volume. Am J Clin Nutr 2010; 92: 408-415.
37. Shaheen SO, Jameson KA, Syddall HE, et al. The relationship of dietary patterns with adult lung function and COPD. Eur Respir J 2010; 36: 277-284.
38. Burchfiel CM, Marcus EB, Sharp DS, et al. Characteristics associated with rapid decline in forced expiratory volume. Ann Epidemiol 1996; 6: 217-227.
39. Bakke PS, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995; 141: 1080-1088.
40. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-760.
41. de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011; 183: 891-897.
42. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest 2002; 121: 370-376.
43. Montes de Oca M, Talamo C, Perez Padilla R, et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med 2008; 102: 642-650.
44. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011; 139: 752-763.
45. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 2005; 365: 1629-1635.
46. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758-764.
47. Menezes AMB, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007; 30: 1180-1185.
48. Blanc PD, Eisner MD, Balmes JR, et al. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Industrial Med 2005; 48: 110-117.
49. Smith KR, Mehta S, Feuz M. Indoor air pollution from household use of solid fuels: comparative quantification of health risks. In: Ezzati MLA, Rodgers A, Murray CJL, eds. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, World Health Organisation, 2004; pp. 1435-1493.
50. Chapman RS, He X, Blair AE, et al. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 2005; 331: 1050-1055.
51. Eisner M, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693-718.